EFFICACY OF ADJUVANT 9-WEEKS TRASTUZUMAB IN NODE-NEGATIVE T1A/B HER2-POSITIVE BREAST CANCER

---

Sendur M. A. , Aksoy S., Uncu D., Demir H., Yuksel S., Ekinci A. S. , ...More

39th ESMO Congress (ESMO), Madrid, Spain, 26 - 30 September 2014, vol.25

• Publication Type: Conference Paper / Summary Text
• Volume: 25
• Doi Number: 10.1093/annonc/mdu327.44
• City: Madrid
• Country: Spain